Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial

BACKGROUND: Some patients develop recurrence after curative resection and adjuvant chemotherapy. S-1, an oral fluoropyrimidine, is one of the standard regimens in adjuvant chemotherapy, and is also used in first-line treatment for advanced/metastatic gastric cancer. It is controversial as to whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Seiji, Ohashi, Yasuo, Sasako, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910584/
https://www.ncbi.nlm.nih.gov/pubmed/29678146
http://dx.doi.org/10.1186/s12885-018-4341-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910584/
https://www.ncbi.nlm.nih.gov/pubmed/29678146
http://dx.doi.org/10.1186/s12885-018-4341-6

Ejemplares similares